Clinical Pharmacology I
Clinical Development Plans, Clinical Pharmacology studies and Phase II clinical trials with novel agents in the following therapeutic areas:
CNS
- Neuropathic Pain and nociceptive pain
- Migraine
- Epilepsy
- Stroke
- Psychosis
- Parkinson’s Disease
- Muscle Relaxants
- Dementia
Endocrinology
- Type II Diabetes
- Dyslipidaemia
Immunology
- Allergy
- Immunosuppression
Oncology
- Targetted therapy for solid tumors
- Non Hodgkin’s Lymphoma (monoclonal antibody)
- Small Cell Bronchial Carcinoma
- Colorectal cancer
- Chemotherapy induced nausea and vomiting
Cardiovascular
- Cardiac Failure
- Thrombosis
- Sickle Cell Disease
Infectious Disease
- Antiviral agents for herpes simplex and zoster
- Phase I evaluation of antimalarials
Respiratory
- Performance of face masks
- Asthma
- Cough